Status:
RECRUITING
Exparel and Education to Avoid Opioids After Carpal Tunnel Release
Lead Sponsor:
Kettering Health Network
Collaborating Sponsors:
American Society for Surgery of the Hand
Conditions:
Carpal Tunnel Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group wi...
Detailed Description
As has become apparent in the media, as well as in the clinical practice of nearly every type of medicine over the last few years, the nation is currently experiencing an opioid epidemic. This is a si...
Eligibility Criteria
Inclusion
- carpal tunnel syndrome diagnosed either by physical exam or EMG
- age \>18.
Exclusion
- allergy to bupivacaine
- pre-operative opioid usage within the last six months
- patients allergic to Percocet or acetaminophen
- patients taking tricyclic antidepressants (interaction with bupivacaine)
- vulnerable populations (prisoners or pregnant women)
Key Trial Info
Start Date :
February 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT03867539
Start Date
February 15 2019
End Date
March 31 2025
Last Update
March 28 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Orthopedic Associates of Southwest Ohio
Dayton, Ohio, United States, 45414
2
Orthopedic Associates of Southwest Ohio
Dayton, Ohio, United States, 45459